The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Value Outlook For The Cardiac Biomarkers Market Through 2030?
The cardiac biomarkers market has experienced significant expansion recently. Projections indicate its size will increase from $21.19 billion in 2025 to $24.22 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.3%. Historically, this growth has been driven by several factors, including a rise in cardiovascular disease cases, the expansion of emergency cardiac care services, increased adoption of laboratory diagnostics, the expanding application of biomarker-based diagnosis, and advancements in immunoassay technologies.
The size of the cardiac biomarkers market is anticipated to undergo significant growth in the near future. The market’s value is forecast to climb to $42.21 billion by the year 2030, achieving a compound annual growth rate (CAGR) of 14.9%. Contributing factors to this growth during the projected period include an escalating demand for rapid cardiac diagnostics, the rising uptake of decentralized testing models, an expansion in preventive cardiology screening initiatives, increasing investments directed towards advanced diagnostic platforms, and the enhanced integration of digital health analytics. Significant trends observed throughout the forecast period involve a greater uptake of high-sensitivity troponin tests, an increasing application of point-of-care cardiac testing, an expanding need for rapid diagnostic kits, the broadening scope of multiplex cardiac biomarker panels, and a heightened emphasis on identifying cardiac risk at an early stage.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10234&type=smp
Which Strategic Drivers Are Supporting The Cardiac Biomarkers Market Development?
The increasing healthcare spending is projected to drive the expansion of the cardiac biomarker market in the future. Health expenditures encompass all expenses related to delivering health services, family planning, nutrition initiatives, and health-focused emergency assistance. Spending on cardiac biomarkers in healthcare seeks to enhance early detection, facilitate personalized treatment, and optimize resource allocation, which could lower the total costs linked to cardiovascular ailments. As an example, a May 2024 report from the Office for National Statistics, a UK government department, indicated that overall healthcare spending nominally increased by 5.6% between 2022 and 2023, significantly higher than the mere 0.9% growth observed in 2022. Consequently, the growing healthcare expenditures are fueling the expansion of the cardiac biomarker market.
What Are The Major Segment Categories Within The Cardiac Biomarkers Market?
The cardiac biomarkers market covered in this report is segmented –
1) By Biomarker Type: Creatine Kinase (CK-Mb), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA)
2) By Location Of Testing: Point Of Care Testing, Laboratory Testing
3) By Application: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome (ACS), Atherosclerosis, Other Applications
4) By End User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-Mb): CK-Mb Test Kits, CK-Mb Diagnostic Panels
2) By Troponins: Troponin I Test Kits, Troponin T Test Kits, Troponin Diagnostic Panels
3) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
4) By Natriuretic Peptides (BNP And NT-proBNP): BNP Test Kits, NT-ProBNP Test Kits, Natriuretic Peptides Diagnostic Panels
5) By Ischemia Modified Albumin (IMA): IMA Test Kits, IMA Diagnostic Panels
What Trends Are Shaping The Cardiac Biomarkers Market Structure?
Leading companies in the cardiac biomarker markets are dedicated to creating groundbreaking assays to expand their product ranges, aiming to better patient outcomes and address currently unmet medical requirements. These innovative biomarker assays foster advancements in cardiac diagnostics, significantly improving accuracy and broadening diagnostic capacities. For example, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., a medical devices and solutions provider firm from China, introduced two novel cardiac biomarkers: high-sensitivity troponin I (hs-cTnI) and NT-proBNP. These additions strengthen Mindray’s varied selection of cardiac biomarkers used for detecting and overseeing cardiovascular diseases (CVDs).
Which Companies Are Engaged In The Cardiac Biomarkers Market Environment?
Major companies operating in the cardiac biomarkers market are F. Hoffmann-La Roche AG, Siemens Healthineers AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Bio-Rad Laboratories Inc, bioMérieux SA, QuidelOrtho Corporation, Randox Laboratories Ltd, Becton Dickinson and Company, Tosoh Corporation, PerkinElmer Inc, Grifols S.A., DiaSorin S.p.A., Sysmex Corporation, Lepu Medical Technology (Beijing) Co. Ltd, Mindray Bio-Medical Electronics Co. Ltd, Fujirebio Holdings Inc, Euroimmun AG, Beckman Coulter Inc, Trinity Biotech plc
Access The Complete Cardiac Biomarkers Market Report:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report
Which Region Contributes The Most To The Cardiac Biomarkers Market?
North America was the largest region in the cardiac biomarkers market in 2025. The regions covered in the cardiac biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Cardiac Biomarkers Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=10234&type=smp
Browse Through More Reports Similar to the Global Cardiac Biomarkers Market 2026, By The Business Research Company
Acoustic Insulation Market Report 2026
https://www.thebusinessresearchcompany.com/report/acoustic-insulation-global-market-report
Automotive Acoustic Materials Market Report 2026
https://www.thebusinessresearchcompany.com/report/automotive-acoustic-materials-global-market-report
Automotive Acoustic Engineering Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model